Searchable abstracts of presentations at key conferences in endocrinology

ea0062wd1 | Workshop D: Disorders of the adrenal gland | EU2019

High-risk pregnancy management due to central adrenal insufficiency and gestational diabetes

Outas Mariana Costache , Costache Raluca

We report a case of a 25 years old woman – with central transient hypoadrenalism after the right adrenalectomy for Cushing syndrome. She became pregnant 1 year after surgery while still taking a small dose of cortisol replacement therapy (5 mg Hydrocortisone) for partial recovery of her corticotrophic axis. Her pregnancy has been complicated by gestational diabetes, with good metabolic control under small doses of basal insulin. She increased her substitutive therapy at 2...

ea0063p1154 | Reproductive Endocrinology 2 | ECE2019

A rare cause of secondary amenorrhea in a patient with non-classical CAH due to a uterine middle-line developmental defect: Case report

Outas Mariana Costache , Costache Raluca

Introduction: The female genital developmental defects are not common in non-classical congenital adrenal hyperplasia (CAH). The causes of amenorrhea are multifactorial and are due to the incomplete control of hyperandrogenism as well as the increased progesterone, acting in various modes: blunted LH mid-cycle surge, lack of progestin withdrawal action and antagonise the estradiol action on the endometrium. The overtreatment with glucocorticoid results in the suppression of go...

ea0037ep126 | Steroids, development and paediatric endocrinology | ECE2015

Diagnostic value of amino-terminal peptide of type I procollagen when retesting GH deficiency in the transition period

Costache-Outas Mariana , Procopiuc Camelia , Caragheorgheopol Andra , Costache Raluca , Fica Simona

N-terminal peptide of type I procollagen (P1NP) is a marker of GH (hGH) anabolic action on bone formation. We evaluated the diagnostic value of P1NP in GH deficiency (GHD) in the transition period using receiver operating characteristic (ROC) plot analysis. We compared the diagnostic value of P1NP with IGF1. 16 male patients (chronological age, 16.6–21.5) with GH replacement therapy during childhood (ten IGHD and six MPHD) were evaluated at minimum 3 months after completi...